News
1d
The Print on MSNBlockbuster semaglutide set to go off patent, Indian pharma sees a multi-billion-dollar opportunityPharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and ...
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...
Provides actionable insights, profiling the company's pipeline products, and enhancing competitive strategy development for stakeholdersDublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The "Venus Medtech ...
Investing in clinical-stage biotechnology always carries significant risks, and aTyr is no exception. The company reported a ...
2h
Global News - Inquirer.net on MSNWill China’s home-grown obesity drugs reshape global weight loss market?July, video editor Meng Meng, 38, has been injecting herself with a weekly weight loss drug, hoping it will finally help her ...
A few years have passed since the height of the COVID-19 pandemic, but but researchers estimate millions of people are still ...
Texas hates when people get high, but the state is on its way toward legalizing ibogaine, a potent, potentially fatal ...
So many people in western countries are turning to weight loss drugs such as Wegovy/Ozempic and Mounjaro that concerns have ...
Obesity medicine specialist Sue Pedersen says the updates also focus on individualizing care and move away from relying on ...
The Trump Administration said this week it is pulling half a billion dollars from U.S. government-funded research projects to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results